The Fort Worth Press - BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events

USD -
AED 3.672498
AFN 63.999702
ALL 82.464942
AMD 358.505756
ANG 1.790403
AOA 917.498647
ARS 1549.870021
AUD 1.484032
AWG 1.8025
AZN 1.696134
BAM 1.779156
BBD 2.017129
BDT 124.690139
BGN 1.77347
BHD 0.378157
BIF 3007.43672
BMD 1
BND 1.291033
BOB 11.682086
BRL 5.7845
BSD 1.001496
BTN 94.002656
BWP 14.018585
BYN 3.009424
BYR 19600
BZD 2.014218
CAD 1.43019
CDF 2317.999943
CHF 0.838915
CLF 0.025357
CLP 997.979904
CNY 6.66455
CNH 6.66546
COP 3317.23
CRC 446.292118
CUC 1
CUP 24.035623
CVE 100.306108
CZK 22.17145
DJF 178.348063
DKK 6.78993
DOP 60.867113
DZD 137.008028
EGP 53.678304
ERN 15
ETB 164.376481
EUR 0.90833
FJD 2.296799
FKP 0.758367
GBP 0.757835
GEL 2.594988
GGP 0.758367
GHS 11.732118
GIP 0.758367
GMD 73.501169
GNF 8873.120921
GTQ 7.654066
GYD 209.544342
HKD 7.846035
HNL 26.932961
HRK 6.831965
HTG 131.250142
HUF 330.815503
IDR 18233.75
ILS 3.248749
IMP 0.758367
INR 93.57705
IQD 1518.259596
IRR 1925253.9999
ISK 124.25976
JEP 0.758367
JMD 158.794125
JOD 0.708947
JPY 159.196501
KES 130.050152
KGS 87.449398
KHR 4106.5296
KMF 447.498309
KPW 900.00035
KRW 1338.809943
KWD 0.311439
KYD 0.834633
KZT 445.59873
LAK 22549.202436
LBP 89683.974965
LKR 333.298462
LRD 170.2507
LSL 16.970744
LTL 2.95274
LVL 0.60489
LYD 6.470746
MAD 9.982716
MDL 18.317444
MGA 4555.8128
MKD 55.91772
MMK 2099.8229
MNT 3605.49036
MOP 8.0932
MRU 40.667528
MUR 47.859839
MVR 15.410333
MWK 1736.583325
MXN 18.50519
MYR 4.091198
MZN 63.909632
NAD 16.970667
NGN 1346.080103
NIO 36.851561
NOK 9.64695
NPR 150.403886
NZD 1.81999
OMR 0.384499
PAB 1.001465
PEN 3.415402
PGK 4.572229
PHP 63.736022
PKR 276.920096
PLN 3.99624
PYG 6215.118421
QAR 3.660925
RON 4.854006
RSD 106.818972
RUB 82.598925
RWF 1479.507134
SAR 3.763042
SBD 8.098361
SCR 14.276828
SDG 601.518606
SEK 10.083204
SGD 1.288005
SHP 0.758581
SLE 23.049833
SLL 20969.503664
SOS 572.372042
SRD 37.4535
STD 20697.981008
STN 22.288025
SVC 8.762969
SYP 13002.000337
SZL 16.966036
THB 33.82499
TJS 9.228432
TMT 3.51
TND 3.027513
TOP 2.40776
TRY 50.417195
TTD 6.801694
TWD 32.962498
TZS 2651.997978
UAH 45.525197
UGX 4156.319079
UYU 40.6615
UZS 12027.818082
VES 914.603596
VND 25735
VUV 120.845902
WST 2.802705
XAF 595.82556
XAG 0.021012
XAU 0.0002579996
XCD 2.70255
XCG 1.8049
XDR 0.707052
XOF 595.82556
XPF 108.488699
YER 236.49594
ZAR 16.959115
ZMK 9001.1985
ZMW 20.506056
ZWL 321.999592
SSP 5946.953244
MXV 2.075993
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events

BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events

The comprehensive campaign will include long-form biographical interviews aired on New to The Street's nationally syndicated TV networks, including Bloomberg and FOX Business Network. Additionally, the campaign features short-form TV commercials, iconic billboard placements in New York City and Las Vegas, and participation in exclusive AccreditedEvents.com investor roadshows, connecting BioVie with accredited investors and key stakeholders.

Text size:

New to The Street, a leading FMW Media production, is thrilled to announce its partnership with BioVie Inc. (NASDAQ:BIVI), a clinical-stage biopharmaceutical company developing innovative therapies for neurodegenerative disorders and advanced liver disease. This partnership will launch a dynamic six-part media campaign designed to amplify BioVie's groundbreaking work to audiences across multiple platforms.

"We are excited to partner with BioVie Inc. and showcase their innovative approaches to tackling critical health challenges," said Vince Caruso, CEO and Managing Partner of New to The Street. "This multi-platform campaign will leverage the full power of our media ecosystem-from television to outdoor advertising and investor events-to tell BioVie's story and support their mission of advancing patient care."

As part of the campaign, BioVie's message will reach millions of homes across the U.S. and international markets, with additional exposure through New to The Street's 2.1 million YouTube subscribers and a combined 500,000+ followers on LinkedIn, Instagram, Facebook, and Twitter. Iconic outdoor placements, including the Nasdaq Tower and Reuters Building in Times Square, will amplify the impact of the campaign, offering unparalleled visibility in prime locations.

About BioVie Inc.

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage biopharmaceutical company at the forefront of developing innovative therapies for neurological and neurodegenerative disorders, including Long COVID, Alzheimer's disease (AD), and Parkinson's disease (PD), as well as advanced liver disease.

In neurodegenerative diseases, BioVie's lead candidate bezisterim targets the inflammatory activation of extracellular signal-regulated
kinase (ERK) and nuclear factor-kB (NF-kB). By mitigating neuroinflammation and insulin resistance-key drivers of AD and PD-bezisterim addresses critical pathways without disrupting ERK and NF-kB's homeostatic roles, such as insulin signaling and neuronal growth. Additionally, bezisterim holds promise for alleviating persistent systemic and neuroinflammation in patients with neurological symptoms of Long COVID.

For advanced liver disease, BioVie is advancing BIV201 (continuous infusion terlipressin), an Orphan Drug with FDA Fast Track status. BIV201 is designed to reduce further decompensation in patients with liver cirrhosis and ascites. Its active agent, already approved in the U.S. and 40 other countries for related complications, is progressing toward Phase 3 clinical trials with FDA guidance.

For more information, visit www.bioviepharma.com.

About New to The Street

New to The Street is an FMW Media production and one of the longest-running U.S. and international sponsored and syndicated Nielsen-rated television brands. Since 2009, the program has showcased biographical interview segment shows across major U.S. television networks, including Bloomberg and FOX Business Network, as sponsored programming. Its Nielsen-rated platform reaches millions of homes across the U.S. and international markets, making it a leader in broadcast media.

With a growing audience of over 2.1 million YouTube subscribers and a combined 500,000+ followers across LinkedIn, Instagram, Facebook, and Twitter, New to The Street amplifies its reach beyond traditional TV. The platform further enhances its offerings through its partnership with AMI Accel Media International, providing access to iconic billboards in New York City and Las Vegas, including the Nasdaq Tower and Reuters Building in Times Square, as well as bus shelters in the Financial District.

In addition, its short-form TV commercial division and collaboration with AccreditedEvents.com enable companies to reach accredited investors through exclusive non-deal roadshows, creating a unique, multi-platform media experience.

For more information, visit www.newtothestreet.com.

For Investor Relations Inquiries:
Bruce Mackle
Managing Director, LifeSci Advisors, LLC
[email protected]

For Media Relations Inquiries:
Melyssa Weible
Managing Partner, Elixir Health Public Relations
[email protected]

New to The Street
Monica Brennan
[email protected]

Contact Information

Monica Brennan
Head of Operations
[email protected]

SOURCE: New to The Street

A.Nunez--TFWP